Exploring pharmacokinetics of talazoparib in ABCB1/ABCG2-deficient mice using a novel UHPLC-MS/MS method

A rapid, sensitive, and simple UHPLC-MS/MS method for the determination of the PARP inhibitor talazoparib in mouse plasma was developed and validated using [(13)C,(2)H(4)]-talazoparib as an internal standard (IS). The assay procedure involved extraction of talazoparib and the IS from plasma using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Talebi, Zahra, Garrison, Dominique A., Eisenmann, Eric D., Parmar, Kalindi, Shapiro, Geoffrey I., Rudek, Michelle A., Sparreboom, Alex, Jin, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613910/
https://www.ncbi.nlm.nih.gov/pubmed/37908705
http://dx.doi.org/10.1016/j.heliyon.2023.e20972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613910/
https://www.ncbi.nlm.nih.gov/pubmed/37908705
http://dx.doi.org/10.1016/j.heliyon.2023.e20972

Ejemplares similares